US Long Covid 20% of cases

Which is way higher than the UK figureUploaded 25-05-22CDC, Long covid Latest UK figureshttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections2.8% of the population, self-reportedOf those, 73% symptoms at least 12 weeks44% symptoms at least one yearPost–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021https://www.cdc.gov/mmwr/volumes/71/wr/mm7121e1.htm?s_cid=mm7121e1_e&ACSTrackingID=USCDC_921-DM82414&ACSTrackingLabel=MMWR%20Early%20Release%20-%20Vol.%2071%2C%20May%2024%2C%202022&deliveryName=USCDC_921-DM82414#contribAffPreviously infected with SARS-CoV-2,reported persistent symptoms≥4 weeks after acute COVID-19March 2020–November 2021United States, aged ≥18Incidence of 26 conditions often / previously attributable to post-COVIDAmong all patients aged ≥18 years38% of case-patients experienced an incident condition16% of controls18–64 years35.4% of case-patients experienced at least one incident condition14.6% of controls experienced at least one incident conditionAged ≥65 years45.4% of case-patients experienced at least one incident condition18.5% of controls experienced at least one incident condition.Survivors aged 18–64One in 5Survivors aged ≥65One in 4experiencing an incident condition that might be attributable to previous COVID-19Conditions affected multiple systemscardiovascular, pulmonary, hematologic, renal, endocrine, gastrointestinal, musculoskeletal, neurologic, and psychiatric signs and symptomsHighest risk ratios (RRs)Acute pulmonary embolism18 to 64, RR = 2.1≥65, RR = 2.1RR = 2.1 and 2.2 among persons aged 18–64 and ≥65 years, respectively) and Respiratory signs and symptomsRR = 2.1 in both age groupsCritical to reducing the incidence and impact of post-COVIDImplementation of COVID-19 prevention strategiesRoutine assessment for post-COVID conditionsis critical to reducing the incidence and impact of post-COVIDThe research studyA retrospective matched cohort designMarch 2020–November 202163.4 million unique adult records110 data contributors in the 50 statesCase-patients, 353,164Control patients, 1,640,776Case-patients or control patients with a previous history of one of the included conditions were excludedNo significant differenceCerebrovascular diseaseMental health conditionsSubstance-related disordersDifferences by age group were notedRR for cardiac dysrhythmia18 to 64, RR = 1.7≥65, RR = 1.5Musculoskeletal pain18–64, RR = 1.6≥65, RR = 1.4RRs for 10 incident conditions, significantly higher among those aged ≥65Renal failure, thromboembolic events, cerebrovascular disease, type 2 diabetes, muscle disorders, neurologic conditions, and mental health conditions (including mood disorders, anxiety, other mental conditions, and substance-related disordersLimitationsPatients infected with recent variantsAcute COVID-19 infection might be biased toward a population that is seeking careCOVID-19 vaccination status was not considered in this analysis Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices